(Total Views: 65)
Posted On: 09/20/2023 10:35:46 AM
Post# of 74552

$RLMD News Article - Relmada Therapeutics Announces Efficacy and Safety Results from the Phase 3 Long-Term Study of REL-1017 in Major Depressive Disorder https://marketwirenews.com/news-releases/relm...75455.html


My Twitter: WhyteStocks